Amgen is pricing osteoporosis drug Evenity on par with Radius Health’s competitor Tymlos. But its cardiovascular risk has already drawn…More

As drug-pricing proposals proliferate at the federal level, states are taking their own steps to rein in sticker prices. That fight hasn’t been…More

The finger-pointing between pharma companies and pharmacy benefits managers went to Washington Wednesday, when a congressional committee questioned the two…More

When Merck & Co. changed its own rules last year to keep CEO Ken Frazier beyond mandatory retirement age, that…More

In the latest move by a drugmaker to address insulin pricing criticism, Sanofi is rolling out a subscription model to…More

This may be a first: House Oversight and Government Reform Committee members are urging pharma CEOs to stonewall instead of…More